ATXG vs GSK · $3.7M cap vs P/E 13, $103.31B cap
Addentax Group Corp (ATXG) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Addentax Group Corp (ATXG) is a integrated freight & logistics company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ATXG revenue for 2026-03-31 was $0. Net income was -$4.5M. Revenue was down 100.0% from 2025-03-31 to 2026-03-31. ATXG currently screens at market cap $3.7M.
GSK does not have a complete income-statement cache yet.
ATXG currently screens at market cap $3.7M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ATXG and GSK stock pages for the full models.
Not investment advice.